Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Ischemic nephropathy.

C F Nobert1, J A Libertino

  • 1Institute of Urology, Lahey Clinic Medical Center, Burlington, Massachusetts 01805, USA.

Current Opinion in Urology
|October 13, 2006
PubMed
Summary
This summary is machine-generated.

Ischemic nephropathy, a cause of kidney failure, is increasing. Revascularization can improve kidney function, but surgery versus angioplasty needs direct comparison.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Correlation between urodynamic function and 3D cat scan anatomy in neobladders: does it exist?

Neurourology and urodynamics·2009
Same author

Restoration of plakoglobin expression in bladder carcinoma cell lines suppresses cell migration and tumorigenic potential.

British journal of cancer·2005
Same author

Renal autotransplantation.

BJU international·2004
Same author

Urinary incontinence after radical retropubic prostatectomy: the outcome of a surgical technique.

BJU international·2003
Same author

Loss of heterozygosity and microsatellite instability at chromosomal sites 1Q and 10Q in morphologically distinct regions of late stage prostate lesions.

The Journal of urology·2001
Same author

Ca 125 as a marker of tumor activity in advanced urothelial malignancy.

The Journal of urology·2001

Area of Science:

  • Nephrology
  • Vascular Medicine
  • Renal Disease

Background:

  • Ischemic nephropathy is a significant and growing cause of end-stage renal disease.
  • Prevalence is high in patients with vascular disease, hypertension, and chronic kidney disease.

Purpose of the Study:

  • To review the current understanding and management of ischemic nephropathy.
  • To highlight the role of revascularization in preserving renal function.

Main Methods:

  • Review of current literature on ischemic nephropathy.
  • Discussion of diagnostic modalities, including angiography and ultrasound.
  • Evaluation of treatment options: surgical revascularization versus medical management.

Main Results:

Related Experiment Videos

  • Angiography is the gold standard for diagnosis, but clinical criteria and ultrasound are recommended for screening.
  • Surgical revascularization can halt or reverse renal function decline.
  • Medical treatment is less effective than surgical intervention.

Conclusions:

  • Ischemic nephropathy is a critical pathway to end-stage renal disease requiring prompt diagnosis and intervention.
  • Surgical revascularization offers better outcomes than medical management.
  • Further studies are needed to compare angioplasty/stent placement directly with surgery for optimal treatment selection.